Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates-Reference-Cited by-同舟云学术

Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates

Published:2015-03-17 Issue:8 Volume:56 Page:2373-2378
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Zent Clive S.,Call Timothy G.,Bowen Deborah A.,Conte Michael J.,LaPlant Betsy R.,Witzig Thomas E.,Ansell Stephen M.,Weiner George J.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1016932

Reference18 articles.

1. Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies

2. A Pilot Trial of Rituximab and Alemtuzumab Combination Therapy in Patients with Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)

3. Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab

4. Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab

5. Phase II study of alemtuzumab–rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustainable production and pharmaceutical applications of β-glucan from microbial sources;Microbiological Research;2023-09

2. The Potential Functions and Mechanisms of Oat on Cancer Prevention: A Review;Journal of Agricultural and Food Chemistry;2022-11-14

3. The role of neutrophils in trained immunity;Immunological Reviews;2022-10-03

4. Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies;Frontiers in Oncology;2022-05-26

5. From Cancer Therapy to Winemaking: The Molecular Structure and Applications of β-Glucans and β-1, 3-Glucanases;International Journal of Molecular Sciences;2022-03-15